All In MedTech

Device Trial Radar · NCT06511934

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)

Intuitive, Complete Neural Control of Tablet Computers for Communication

Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

6

Planned (sponsor's estimate)

Start

Jul 22, 2024

Primary completion

Jul 30, 2027

Study completion Jul 30, 2028

Sponsor

Lead sponsor
Leigh R. Hochberg, MD, PhD.Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Brown University; Stanford University; National Institute on Deafness and Other Communication Disorders (NIDCD)
First posted
Jul 22, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

People with brainstem stroke, advanced amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), or other disorders can become unable to move or speak despite being awake and alert. In this project, the investigators seek to further translate knowledge about interpreting brain signals related to movement, and to further develop an intracortical brain-computer interface (iBCI) that could restore rapid and intuitive use of communication apps on tablet computers by people with paralysis.

Conditions

  • Brainstem Stroke
  • ALS
  • Tetraplegia
  • Spinal Cord Injuries
  • Cervical Spinal Cord Injury

Interventions

  • BrainGate Neural Interface SystemDevice

    Placement of the BrainGate2 sensor(s) into arm-hand motor-related cortex.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensor implant duration for at least one-year without any device-related Serious Adverse Events or explantTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Masssachusetts General Hospital

    Boston, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.